Introducing ALZET?ew Model 2006 Pump  Sign up for PNAS Online eTocs
Link: Info for AuthorsLink: Editorial BoardLink: AboutLink: SubscribeLink: AdvertiseLink: ContactLink: Sitemap Link: PNAS Home
Proceedings of the National Academy of Sciences
Link: Current Issue "" Link: Archives "" Link: Online Submission ""  Link: Advanced Search

Published online on November 3, 2003, 10.1073/pnas.2336095100
PNAS | November 11, 2003 | vol. 100 | no. 23 | 13121-13122


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a colleague
Right arrow Companion article to this Commentary
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poulos, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poulos, T. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg  
What's this?

 Previous Article  | Table of Contents |  Next Article 

Commentary
Cytochrome P450 flexibility

Thomas L. Poulos *

Departments of Molecular Biology and Biochemistry, Physiology and Biophysics, and Chemistry, and Program in Macromolecular Structure, University of California, Irvine, CA 92697-3900

Cytochrome P450 refers to a group of enzymes that catalyze the monooxygenation of various organic molecules in the following reaction:

P450s are best known for their role in drug metabolism and detoxification. Humans have 57 functional P450 genes and 46 pseudogenes (http://drnelson.utmem.edu/human.genecount.html), and several of these, located in liver microsomes, are induced by a variety of foreign organic molecules. Hydroxylation of these substances by P450s renders these relatively insoluble organic compounds more soluble for easier elimination. In addition, P450s participate in the metabolism of sex hormones, vitamin D, and bile acids in mammals (1, 2); ecdysones in insects (3); and terpenes in plants (4). P450s also play an important role in microorganisms in the use of various organic compounds as carbon sources and in the production of important natural products such as antibiotics.

P450s range in size from 40 to 50 kDa and contain a single heme group. Oxygen binds to the heme iron where the enzyme catalyzes cleavage of the oxygen O—O bond, leaving behind an iron-linked oxygen atom that provides a potent oxidant. The substrate is held precisely in place such that the correct carbon atom is close to the iron-linked O atom for regio- and stereoselective hydroxylation. In general, those P450s involved in the production of important intermediates such as in steroid metabolism are highly specific. However, many of the drug-metabolizing P450s are not specific and are capable of hydroxylating a variety of diverse and unrelated compounds. Several P450 crystal structures now are known, and it was not too surprising, based on sequence alignments, that the overall fold is maintained in all P450s (Fig. 1). A particularly challenging problem, however, is . . . [Full Text of this Article]

* E-mail: poulos@uci.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg    What's this?

Companion article to this Commentary:

From The Cover: An open conformation of mammalian cytochrome P450 2B4 at 1.6-Å resolution
Emily E. Scott, You Ai He, Michael R. Wester, Mark A. White, Christopher C. Chin, James R. Halpert, Eric F. Johnson, and C. David Stout
PNAS 2003 100: 13196-13201. [Abstract] [Full Text]  



This article has been cited by other articles in HighWire Press-hosted journals:


Home page
Mol. Endocrinol.Home page
Y. Hong, B. Yu, M. Sherman, Y.-C. Yuan, D. Zhou, and S. Chen
Molecular Basis for the Aromatization Reaction and Exemestane-Mediated Irreversible Inhibition of Human Aromatase
Mol. Endocrinol., February 1, 2007; 21(2): 401 - 414.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
M. S. Achary, A. B. M. Reddy, S. Chakrabarti, S. G. Panicker, A. K. Mandal, N. Ahmed, D. Balasubramanian, S. E. Hasnain, and H. A. Nagarajaram
Disease-Causing Mutations in Proteins: Structural Analysis of the CYP1b1 Mutations Causing Primary Congenital Glaucoma in Humans
Biophys. J., December 15, 2006; 91(12): 4329 - 4339.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M. Janner, A. V Pandey, P. E Mullis, and C. E Fluck
Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein.
Eur. J. Endocrinol., July 1, 2006; 155(1): 143 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Krone, Y. Grischuk, M. Muller, R. E. Volk, J. Grotzinger, P.-M. Holterhus, W. G. Sippell, and F. G. Riepe
Analyzing the Functional and Structural Consequences of Two Point Mutations (P94L and A368D) in the CYP11B1 Gene Causing Congenital Adrenal Hyperplasia Resulting from 11-Hydroxylase Deficiency
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2682 - 2688.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Zhao, F. P. Guengerich, A. Bellamine, D. C. Lamb, M. Izumikawa, L. Lei, L. M. Podust, M. Sundaramoorthy, J. A. Kalaitzis, L. M. Reddy, et al.
Binding of Two Flaviolin Substrate Molecules, Oxidative Coupling, and Crystal Structure of Streptomyces coelicolor A3(2) Cytochrome P450 158A2
J. Biol. Chem., March 25, 2005; 280(12): 11599 - 11607.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
P. A. Williams, J. Cosme, D. M. Vinkovic, A. Ward, H. C. Angove, P. J. Day, C. Vonrhein, I. J. Tickle, and H. Jhoti
Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone
Science, July 30, 2004; 305(5684): 683 - 686.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. J. Dickmann, C. W. Locuson, J. P. Jones, and A. E. Rettie
Differential Roles of Arg97, Asp293, and Arg108 in Enzyme Stability and Substrate Specificity of CYP2C9
Mol. Pharmacol., April 1, 2004; 65(4): 842 - 850.
[Abstract] [Full Text]